Percutaneous Endoscopic Gastrostomy and Early Mortality

Wk, Clarkston; Oj, Smith; Jm, Walden

doi:10.1097/00007611-199012000-00015

Cited by 39 publications

(20 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our series, mortality due to underlying disease is similar to that reported by other authors [9,12,17], but unlike Clarkston et al [12], for this parameter we found no statistically significant difference between patients with neurological deficits and those with malignancy. As we are dealing with patients with advanced neoplasias or severe neurological disease, their life expectancy is short, and it is not yet possible to identify which patients will live long enough for gastrostomy to be considered justi fied.…”

Section: Discussionsupporting

confidence: 90%

“…In a series of 23 cancer patients who underwent gastrostomy ( 18 PEG and 5 fluoroscopic gastrostomies), Luetzow et al [7] observed two major complications: one gastro-intestinal bleeding and one ascitic fluid leakage. In their series of 38 patients, Clarkston et al [12] found a statistically significant differ ence between complications in patients with neurologic deficit and patients with malignancy (21 vs. 60%). On the other hand, Gibson et al [6] compared complication rates in neoplastic and in neurologic patients who underwent PEG, and found a statistically significant lower complica tion rate in the neoplastic group (5 vs. 14%).…”

Section: Discussionmentioning

confidence: 92%

See 1 more Smart Citation

Percutaneous Endoscopic Gastrostomy for Feeding

Pucciarelli

Toppan

Fede

et al. 1996

ORL

View full text Add to dashboard Cite

The most common indications for percutaneous endoscopic gastrostomy (PEG) are neurologic deficits precluding adequate oral nutrition. The aim of this study was to ascertain whether PEG is as feasible, safe and effective in patients with advanced oropharyngeal, oesophageal and pulmonary carcinoma as it is in patients with neurologic deficit. PEG, attempted in 108 consecutive patients, was successful in 100 (overall success rate of 92%). On the basis of primary disease, the patients were subdivided into two groups: patients with neurologic diseases (group A, n = 50) and patients with oropharyngeal, oesophageal and lung carcinoma precluding adequate oral nutrition (group B, n = 50). No statistically significant difference was found between the PEG placement success rates of the two groups. Of the patients with PEG placement 1 died and 2 had major complications. 15 out of 50 patients in group A and 11 out of 50 in group B had minor complications. No statistically significant differences were found between the mortality and morbidity rates of the two groups. Duration of nutrition was similar in both groups. In particular, 46% group A patients and 46% group B patients were PEG-fed for more than 3 months. A wider use of PEG is suggested in patients with advanced oropharyngeal, oesophageal and pulmonary carcinoma precluding adequate oral nutrition.

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Discussionmentioning

confidence: 92%

Percutaneous Endoscopic Gastrostomy for Feeding

Pucciarelli

Toppan

Fede

et al. 1996

ORL

View full text Add to dashboard Cite

show abstract

“…Despite the difficult conditions seen in such patients, thus far no major technical problems have been encountered during tube placement [1,8,9]. Frequently mentioned contraindications, such as infiltration of the stomach by tumor, ascites, peritoneal carcinosis, etc., have been deliberately left out of the published accounts [1,5,11,16]; apart from a relevant coagulation disturbance, the sole contraindication in our study was failure of transillumination.…”

Section: Discussionmentioning

confidence: 99%

Percutaneous endoscopic gastrostomy/jejunostomy (PEG/PEJ) for decompression in the upper gastrointestinal tract

et al. 1999

View full text Add to dashboard Cite

show abstract

“…A third of these patients, however, were being treated for carcinoma. Clarkston et al 37 found a 60 day mortality of 43% post tube placement. Fay et al 38 found that overall mortality for patients with both gastrostomy and nasoenteric tubes approached 50% at 120 days.…”

Section: Special Considerationsmentioning

confidence: 98%